Roles of nitric oxide in inflammatory downregulation of human cytochromes P450

被引:39
作者
Aitken, Alison E. [1 ]
Lee, Choon-Myung [1 ]
Morgan, Edward T. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
nitric oxide; cytochrome P450; CYP2136; inflammation; cytokines; protein degradation;
D O I
10.1016/j.freeradbiomed.2007.12.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to determine the role of nitric oxide (NO) in the downregulation of human cytochrome P450 (CYP) enzymes and mRNAs by an inflammatory stimulus in cultured human hepatocytes. We focused on CYP2B6 because previous studies showed that rat CYP 13 proteins undergo an NO-dependent degradation in response to inflammatory stimuli. To ensure high-level expression of CYP2B6, the inducer phenytoin was present at all times. Stimulation of cells with a mixture of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma (ILmix) downregulated CYP2B6 mRNA and protein to 9 and 19% of control levels. The NO donor NOC-18 downregulated CYP2B6 protein to 30% of control, with only a small effect on CYP2B6 mRNA. Nitric oxide synthase inhibitors attenuated the downregulation of CYP2B6 protein but not mRNA by ILmix. These findings demonstrate that the posttranscriptional NO-dependent downregulation of CYP2B enzymes, observed previously in rat hepatocytes, is conserved in human CYP2B6. This mechanism is specific for CYP2B6 among the enzymes tested. No evidence was found for regulation of CYP2E1 mRNA or protein by NO. NOC-18 treatment downregulated CYP3A4 mRNA to 50% of control. However, NOS inhibitors failed to block the effects of ILmix on CYP3A4 expression. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1161 / 1168
页数:8
相关论文
共 49 条
[1]  
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[2]   Regulation of drug-metabolizing enzymes and transporters in inflammation [J].
Aitken, AE ;
Richardson, TA ;
Morgan, ET .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :123-149
[3]   Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines [J].
Bleau, AM ;
Levitchi, MC ;
Maurice, H ;
du Souich, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1777-1784
[4]   Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure [J].
Carcillo, JA ;
Doughty, L ;
Kofos, D ;
Frye, RF ;
Kaplan, SS ;
Sasser, H ;
Burckart, GJ .
INTENSIVE CARE MEDICINE, 2003, 29 (06) :980-984
[5]  
Carlson TJ, 1996, MOL PHARMACOL, V49, P796
[6]   REGULATION OF CYTOCHROME-P450 2C11 (CYP2C11) GENE-EXPRESSION BY INTERLEUKIN-1, SPHINGOMYELIN HYDROLYSIS, AND CERAMIDES IN RAT HEPATOCYTES [J].
CHEN, JQ ;
NIKOLOVAKARAKASHIAN, M ;
MERRILL, AH ;
MORGAN, ET .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :25233-25238
[7]   Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin [J].
Cheng, PY ;
Wang, ML ;
Morgan, ET .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :1205-1212
[8]   Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells [J].
Chun, YJ ;
Lee, S ;
Yang, SA ;
Park, S ;
Kim, MY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (05) :687-692
[9]   Cytochrome P450 ubiquitination: Branding for the proteolytic slaughter? [J].
Correia, MA ;
Sadeghi, S ;
Mundo-Paredes, E .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :439-464
[10]  
Donato MT, 1997, J PHARMACOL EXP THER, V281, P484